Pathologic processes associated with the effect of ischemia on the pancreas are not yet fully investigated and searching for ways of reduction of the damaging effect of ischemia for providing full organ regeneration are of certain interest. Protective properties of xymedone with regard to pathologic processes in pancreas were studied on a model of total ischemia created by ligation of the coeliac and cranial mesenteric artery for 0 to 90 min. Pathologic structural changes in the pancreas in case of ischemia lasting up to 30 min are minor and therefore fully reversible. On the contrary, ischemia duration of more than 60 min in the group of animals not injected with xymedone can be seen as critical. We conclude that prior intraperitoneal injection of xymedone in the dose of 3.3 mg/kg helps to delay the development of pathologic processes in pancreatic parenchyma by approximately 30 min.
BioNanoScience – Springer Journals
Published: May 30, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera